Adam Kaplin
2023
In 2023, Adam Kaplin earned a total compensation of $594K as Former Chief Scientific Officer at Akers Biosciences, a 68% increase compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Option Awards | $235,245 |
| Salary | $250,000 |
| Other | $8,750 |
| Total | $593,995 |
Kaplin received $250K in salary, accounting for 42% of the total pay in 2023.
Kaplin also received $100K in bonus, $235.2K in option awards and $8.8K in other compensation.
Rankings
In 2023, Adam Kaplin's compensation ranked 1,842nd out of 3,006 executives tracked by ExecPay. In other words, Kaplin earned more than 38.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,842 out of 3,006 | 39th |
Division Manufacturing | 1,060 out of 1,650 | 36th |
Major group Chemicals And Allied Products | 665 out of 918 | 28th |
Industry group Drugs | 649 out of 881 | 26th |
Industry In Vitro and In Vivo Diagnostic Substances | 4 out of 14 | 71st |
Source: SEC filing on November 1, 2024.
Kaplin's colleagues
We found three more compensation records of executives who worked with Adam Kaplin at Akers Biosciences in 2023.
News
Akers Biosciences Chief Medical Officer Christopher Chapman's 2023 pay jumps 1,002% to $2.9M
November 1, 2024
Akers Biosciences CSO Adam Kaplin's 2022 pay falls 93% to $354K
June 30, 2023
Akers Biosciences CSO Adam Kaplin's 2021 pay jumps 1,350% to $5.2M
October 26, 2022
Akers Biosciences CEO Christopher Schreiber's 2020 pay jumps 1,909% to $1.1M
November 22, 2021